Acta Med. 2007, 50: 149-153
https://doi.org/10.14712/18059694.2017.73
The Pattern of Acute Myocardial Infarction in People with Opportunistic Infections
References
1. Blood Coagul Fibrinolysis 1991; 2:713–21.
U, Lindahl AK, Lacobson PB, Sandset PM. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients.
2. J Clin Invest 1984; 73:842–7.
< M, Kahane I, Yatziv S. Role of superoxide anion in host cell injury induced by Mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells. https://doi.org/10.1172/JCI111279>
<PubMed>
3. Curr Mol Med 2006; 6:439–56.
< L, Martinez-Gonzalez J, Llorente-Cortes V, Rodriguez C, Padro T. Cell biology and lipoproteins in atherosclerosis. https://doi.org/10.2174/156652406778018725>
4. Biochemistry (Moscow) 1997; 62:659–68.
LA. Biochemistry of inflammatory processes and vessel damage. The role of neutrophils.
5. Proc Natl Acad Sci USA 1974; 71:464–68.
< S, Teplitz M, Revel JP. Interaction of mycoplasmas with cell cultures, as visualized by electron microscopy. https://doi.org/10.1073/pnas.71.2.464>
<PubMed>
6. Lancet 1968; 2: 203–4.
< JP, Sultan Y, Larrieu MJ. A new familial platelet disease. https://doi.org/10.1016/S0140-6736(68)92591-9>
7. Dokl Akad Nauk 1999; 365: 842–5.
OA, Mal’tseva LI, Chernov VM, Popova NV. Abnormal structure of blood cells and related hemostasis reactions during persistence of mycoplasma infection in humans (In Russian).
8. Microbiology (Moscow) 2005; 74:428–33.
< VM, Mukhametshina NE, Gogolev YuV, Abdrakhimov FA, Chernova OA. Adaptive reaction of mycoplasmas in vitro: „viable but unculturable forms“ and nanocells of Acholeplasma laidlawii. https://doi.org/10.1007/s11021-005-0084-x>
9. Int J Cardiol 2001; 77: 293–7.
< I, Kacmaz M, Cimen MY, Buyukkocak U, Ozturk HS. Blood oxidant/antioxidant status of atherosclerotic patients. https://doi.org/10.1016/S0167-5273(00)00450-2>
10. Frimmel G, ed. Immunological methods of investigation (In Russian). Moscow: Medicine, 1987.
11. BEBM 1989; 2:437–39.
ZA, Popov EG, Gavrilov IYu, Posin Eya, Markosyan RA. A new methodical approach to research of platelet aggregation in vitro.
12. Virchows Arch 2000; 437:528–33.
H, van der Wal AC, Teeling P, van der Loos CM, Becker AE. Metallothionein in human atherosclerotic lesions: a scavenger mechanism for reactive oxygen species in the plaque?
13. Rev Inst Med Trop S Paulo 2002; 44:217–24.
< ML, Ranures JAF. Infections agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction. https://doi.org/10.1590/S0036-46652002000400007>
14. Arq Bras Cardiol 2003; 81:12–22.
< ML, Reis MM, Sambiase NV, Palomino SA, Castelli JB, Gutierrez PS, Aiello VD, Ramires JA. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. https://doi.org/10.1590/S0066-782X2003000900001>
15. J Immunol 1973; 111:1219–27.
PH, Creighton WD, Miescher PA. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol.
16. Immunochem 1965; 2:235–40.
< G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigen by single radial immunodiffusion. https://doi.org/10.1016/0019-2791(65)90004-2>
17. J Clin Hypertens (Greenwich) 2006; 8:31–8.
< RP. Nitric oxide mechanisms in the pathogenesis of global risk. https://doi.org/10.1111/j.1524-6175.2006.05838.x>
<PubMed>
18. Circulation 1996; 94:1226–32.
< JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. https://doi.org/10.1161/01.CIR.94.6.1226>
19. In Vitro Cell Dev Biol Anim 1995; 31:880–5.
< M, Kobayashi M, Mitsup Y. Elevation of endothelin biosynthesis in human endothelial cells with mycoplasma infection. https://doi.org/10.1007/BF02634574>
20. Z Med Labortech 1970; 11:249–71.
J. The technic of complement fixation reaction.
21. Microbiology 1994; 140:2043–8.
< K, Ehlers S, Jacobs E. Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with Mycoplasma pneumoniae. https://doi.org/10.1099/13500872-140-8-2043>
22. J Immunol 1996; 156:670–8.
G, Roman-Roman S, Castedo M, Dutilleul V, Susin S, Marchetti P, Geuskens M, Kroemer G. Effects of Mycoplasma fermentans on the myelomonocytic lineage. Different molecular entities with cytokine-inducing and cytocidal potential.
23. Microbiol Mol Biol Rev 1998; 62:1094–1156.
S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas.
24. Atherosclerosis 2001; 154:87–96.
< Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, Nishi H, Inoue N, Yokoyama M. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. https://doi.org/10.1016/S0021-9150(00)00468-8>
25. J Lipid Res 1984; 25:1109–16.
UP, Fisher M, Witztum JL, Curtiss LK. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine.
26. Varma A, ed. Handbook of atomic absorption analysis. Vol. I. Boca Raton: CRC Press, 1985.
27. Heart 1998; 80:14–8.
< AC, Piek JJ, de Boer OJ, Koch KT, Teeling P, van der Loos CM, Becker AE. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. https://doi.org/10.1136/hrt.80.1.14>
<PubMed>
28. Clin Microbiol Rev 2005; 18:757–89.
< KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. https://doi.org/10.1128/CMR.18.4.757-789.2005>
<PubMed>
29. Appl Environ Microbiol 2004; 70:1483–86.
< H, Kong F, Jelfs P, James G, Gilbert GL. Simultaneous detection and identification of common cell culture contaminant and pathogenic Mollicutes strains by reverse line blot hybridization. https://doi.org/10.1128/AEM.70.3.1483-1486.2004>
<PubMed>
30. Atherosclerosis 2001; 155:445–53.
< Y, Hayashik K, Shingu T, Yamagota T, Kajiyama G, Kambe M. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. https://doi.org/10.1016/S0021-9150(00)00581-5>